We are live on ! Find out more
BCA

Benchmark Capital Advisors Portfolio holdings

AUM $101M
1-Year Est. Return 0.8%
This Fund
S&P 500
This Quarter Est. Return
+6.65%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$132M
AUM Growth
+$5.73M
Cap. Flow
-$179K
Cap. Flow %
-0.14%
Top 10 Hldgs %
31.6%
Holding
141
New
11
Increased
30
Reduced
56
Closed
10

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.64M
2
NWL icon
Newell Brands
NWL
+$1.16M
3
META icon
Meta Platforms (Facebook)
META
+$1.05M
4
AAPL icon
Apple
AAPL
+$1.02M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$1,000K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.2M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$1.44M
3
VSAT icon
Viasat
VSAT
+$1.26M
4
IEV icon
iShares Europe ETF
IEV
+$1.17M
5
NVS icon
Novartis
NVS
+$1.07M

Sector Composition

Rank Sector Weight
1 Miscellaneous 17.42%
2 Technology 15.72%
3 Real Estate 14.11%
4 Healthcare 13.29%
5 Financials 11.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DELL icon
101
Dell
DELL
$305B
$254K 0.19%
+10,690
New +$236K
PPA icon
102
Invesco Aerospace & Defense ETF
PPA
$8.16B
$253K 0.19%
4,600
+300
+7% +$17K
CAT icon
103
Caterpillar
CAT
$376B
$244K 0.18%
+1,800
New +$269K
VWTR
104
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$244K 0.18%
20,957
-5,000
-19% -$57.1K
LGF.B
105
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$235K 0.18%
+10,000
New +$232K
VATE icon
106
INNOVATE Corp
VATE
$106M
$234K 0.18%
4,000
– –
MIN
107
Aberdeen Intermediate Income Fund
MIN
$279M
$233K 0.18%
60,300
-4,000
-6% -$15.5K
XLV icon
108
State Street Health Care Select Sector SPDR ETF
XLV
$44.6B
$225K 0.17%
2,700
-400
-13% -$33.1K
AABA
109
DELISTED
Altaba Inc
AABA
$220K 0.17%
+3,000
New +$225K
NQP
110
DELISTED
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
$210K 0.16%
16,600
– –
IYY icon
111
iShares Dow Jones US ETF
IYY
$3.06B
$205K 0.16%
+3,000
New +$203K
CNOB icon
112
Center Bancorp
CNOB
$1.61B
$204K 0.15%
8,206
– –
ESI icon
113
Element Solutions
ESI
$8.9B
$145K 0.11%
12,500
-2,500
-17% -$27.3K
BLRX
114
BioLineRX
BLRX
$12.1M
$127K 0.1%
238
– –
FAX
115
abrdn Asia-Pacific Income Fund
FAX
$602M
$111K 0.08%
4,300
-367
-8% -$9.97K
TOO
116
DELISTED
Teekay Offshore Partners L.P.
TOO
$107K 0.08%
40,500
-30,000
-43% -$79.6K
TRIB
117
Trinity Biotech
TRIB
$7.93M
$99K 0.07%
132
-21
-14% -$15.2K
BNBX
118
DELISTED
BNB PLUS CORP
BNBX
– –
0
– –
GSL icon
119
Global Ship Lease
GSL
$1.62B
$60K 0.05%
5,669
– –
CLDX icon
120
Celldex Therapeutics
CLDX
$3.18B
$27K 0.02%
3,627
-40
-1% -$535
PDL.B
121
DELISTED
PRESIDENTAL RLTY CL B
PDL.B
$3K ﹤0.01%
74,000
– –
CL icon
122
Colgate-Palmolive
CL
$72.5B
– –
-5,000
Closed -$358K
HDV
123
iShares Core High Dividend ETF
HDV
$15.2B
– –
-12,000
Closed -$203K
IEV icon
124
iShares Europe ETF
IEV
$1.7B
– –
-25,045
Closed -$1.17M
JCI icon
125
Johnson Controls International
JCI
$86.1B
– –
-13,900
Closed -$490K
2 3 4
5
6

Similar funds

OIMU
Orbis Investment Management (US) San Francisco, California $99.7M AUM 17.51% 1-Year Est. Return
7A
734 Agriculture New York $93.8M AUM 0% 1-Year Est. Return
JCP
Jabre Capital Partners Geneva, Switzerland $87.8M AUM 5.24% 1-Year Est. Return
DCM
Diag Capital Management New York $87.4M AUM
BCEM
Bayou City Energy Management Houston, Texas $85.4M AUM
QAM
Questar Asset Management Minneapolis, Minnesota $85M AUM
CFA
Clarfeld Financial Advisors Tarrytown, New York $120M AUM
BPV
Battery Partners VIII Boston, Massachusetts $121M AUM 101.35% 1-Year Est. Return

Benchmark Capital Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Benchmark Capital Advisors held 141 positions worth $132M, up 4.5% from $127M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Benchmark Capital Advisors's Q2 2018 filing shows 11 new, 30 increased, 56 reduced and 10 closed positions. Its largest new stake was Merck: 29,082 shares worth $1.68M. The largest sale was Bristol-Myers Squibb, an estimated $2.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 17% of assets, down from 20% a quarter earlier, followed by Technology and Real Estate.

  • Benchmark Capital Advisors's largest Q2 2018 buy was Merck: 29,082 shares worth $1.68M.
  • Benchmark Capital Advisors added most to Meta Platforms (Facebook) in Q2 2018, an estimated $1.05M increase.
  • Benchmark Capital Advisors's biggest Q2 2018 reduction was Bristol-Myers Squibb, cutting an estimated $2.2M.
  • Benchmark Capital Advisors fully exited Viasat in Q2 2018, selling an estimated $1.26M.
  • Benchmark Capital Advisors's ten largest holdings make up 32% of its $132M portfolio in Q2 2018.
  • Benchmark Capital Advisors opened 11 new positions and closed 10 in Q2 2018.
  • Benchmark Capital Advisors's portfolio value rose 4.5% quarter-over-quarter to $132M.

Based on Benchmark Capital Advisors's 13F filing for Q2 2018, filed 25 Jul 2018.